-+ 0.00%
-+ 0.00%
-+ 0.00%

*Entrada Therapeutics: Cash Runway Expected Into 3Q 2027 With $255M in Cash, Cash Equivalents and Marketable Securities as of March 31 >TRDA

Dow Jones·05/07/2026 11:17:00

Please log in to view news